Cambridge Investment Research Advisors, Inc. Assertio Holdings, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 20,176 shares of ASRT stock, worth $16,342. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,176
Previous 37,996
46.9%
Holding current value
$16,342
Previous $45,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ASRT
# of Institutions
99Shares Held
29.5MCall Options Held
1.15MPut Options Held
121K-
Nantahala Capital Management, LLC New Canaan, CT8.15MShares$6.6 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$3.55 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.99MShares$2.42 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$1.12 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.1MShares$892,0350.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $39M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...